PPH Stock Overview
VanEck ETF Trust - VanEck Pharmaceutical ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
VanEck ETF Trust - VanEck Pharmaceutical ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$85.44 |
| 52 Week High | US$91.16 |
| 52 Week Low | US$74.05 |
| Beta | 0 |
| 1 Month Change | -4.59% |
| 3 Month Change | 0.80% |
| 1 Year Change | 7.54% |
| 3 Year Change | 23.09% |
| 5 Year Change | 51.03% |
| Change since IPO | 136.94% |
Recent News & Updates
PPH: Ignore The Election Scare, Buy Pharma And Healthcare
Jan 19Healthcare outperforms S&P 500 as large cap pharma rebounds
Sep 22PPH Investors Should Keep On Top Of Regulatory Developments
Aug 26PPH: A Pharmaceutical ETF Delivering Close To 10% Total Return
Apr 13Shareholder Returns
| PPH | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -2.9% | -3.8% | -1.7% |
| 1Y | 7.5% | 24.3% | 22.4% |
Return vs Industry: PPH underperformed the US Capital Markets industry which returned 24.3% over the past year.
Return vs Market: PPH underperformed the US Market which returned 22.4% over the past year.
Price Volatility
| PPH volatility | |
|---|---|
| PPH Average Weekly Movement | 1.4% |
| Capital Markets Industry Average Movement | 3.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PPH has not had significant price volatility in the past 3 months.
Volatility Over Time: PPH's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | n/a | www.vaneck.com/us/en/investments/pharmaceutical-etf-pph/ |
VanEck ETF Trust - VanEck Pharmaceutical ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation. The fund invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors.
VanEck ETF Trust - VanEck Pharmaceutical ETF Fundamentals Summary
| PPH fundamental statistics | |
|---|---|
| Market cap | US$516.14m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs PPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PPH income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PPH perform over the long term?
See historical performance and comparison